Supernus Pharmaceuticals, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:SUPN) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 1.37 B1.35 B1.38 B1.42 B1.45 B1.5 B 負債合計 332.34 M316.58 M318.5 M370.09 M390.93 M423.92 M 純資産合計 1.04 B1.03 B1.06 B1.05 B1.06 B1.08 B 負債および純資産合計 1.37 B1.35 B1.38 B1.42 B1.45 B1.5 B 有利子負債合計 —————— 純負債 ——————

ニュース

Should You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD?

Supernus Pharmaceuticals, Inc. (SUPN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Supernus Pharmaceuticals, Inc. (SUPN) Q1 2026 Earnings Call Transcript

Supernus (SUPN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue Estimates

Bausch Health (BHC) Lags Q1 Earnings Estimates

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs

Biogen Walloped Wall Street's First Quarter Views; Here's What Happened

Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?

Supernus、Barclaysカンファレンスで戦略的成長と将来展望を語る

Supernus at Barclays Conference: Strategic Growth and Future Prospects

Supernus、TDカンファレンスで戦略的多様化を発表